(Q51739350)

English

Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin.

scientific article published on 27 January 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/26816270

Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin. (English)

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/26816270

Michael B. Boffa

2

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/26816270

author name string

T T Marar

1

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/26816270

publication date

27 January 2016

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/26816270

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/26816270

14

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/26816270

4

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/26816270

772-783

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/26816270

Insights into thrombin activatable fibrinolysis inhibitor function and regulation.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

An update on the role of carboxypeptidase U (TAFIa) in fibrinolysis

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

Thrombin and fibrinolysis

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

Activation of thrombin-activable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

Amino acid residues in the P6-P'3 region of thrombin-activable fibrinolysis inhibitor (TAFI) do not determine the thrombomodulin dependence of TAFI activation

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

Thrombomodulin and its role in inflammation.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

Allosteric modulation of the activity of thrombin

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

A role for arginine-12 in thrombin-thrombomodulin-mediated activation of thrombin-activatable fibrinolysis inhibitor.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

Functional analysis of mutant variants of thrombin-activatable fibrinolysis inhibitor resistant to activation by thrombin or plasmin

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

The crystal structure of thrombin-activable fibrinolysis inhibitor (TAFI) provides the structural basis for its intrinsic activity and the short half-life of TAFIa

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

Generation of a stable activated thrombin activable fibrinolysis inhibitor variant

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

In vitro and in vivo characterisation of the profibrinolytic effect of an inhibitory anti-rat TAFI nanobody

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13275

21 January 2018

Identifiers

10.1111/JTH.13275

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/26816270

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/26816270

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51739350&oldid=786978019"